TickerFacts.

Company research / KEQU

Kewaunee Scientific Corp (KEQU)

Build a valuation ↗↓ Download CSV

SEC name KEWAUNEE SCIENTIFIC CORP /DE/ · CIK 0000055529 · Nasdaq · Laboratory Apparatus & Furniture

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Apr 30

For the year ended 2026-04-30, Kewaunee Scientific Corp reported revenue of $282.00M. Revenue grew 17.3% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $277.21M.

Key ratios (year ended 2026-04-30)

28.5%
Gross margin
5.9%
Operating margin
3.4%
Net margin
12.9%
Return on year-end equity
17.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-09-11

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31		2026-04-302025-04-302024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-30
Revenue$277.21M$282.00M$240.47M$203.75M$219.49M$168.87M$147.47M$147.54M$146.55M$158.05M$138.56M
Cost of Revenue$198.07M$201.56M$171.62M$151.70M$183.91M$144.65M$123.48M$124.11M$121.23M$125.89M$111.95M
Gross Profit$79.15M$80.44M$68.86M$52.05M$35.59M$24.22M$23.99M$23.43M$25.32M$32.16M$26.61M
R&D Expensen/a$898.0K$919.0K$920.0K$1.01M$990.0K$1.41M$1.82M$1.55M$1.54M$1.16M
Operating Income$15.06M$16.71M$17.76M$18.28M$5.36M-$2.61M-$1.32M-$2.35M$2.11M$9.92M$6.54M
Depreciation & Amortization$6.32M$6.28M$4.76M$3.12Mn/an/an/an/an/an/an/a
EBITDA$21.39M$23.00M$22.52M$21.41Mn/an/an/an/an/an/an/a
Net Income$8.23M$9.62M$11.40M$18.75M$738.0K-$6.13M-$3.67M-$4.69M$1.53M$5.28M$4.51M
EPS (Diluted)n/a$3.22$3.83$6.38$0.25-$2.20-$1.33-$1.70$0.55$1.90$1.66
Total Assets$175.80M$178.31M$194.65M$134.77M$118.90M$118.77M$89.38M$83.93M$87.22M$85.08M$80.92M
Total Liabilities$98.58M$101.50M$128.41M$78.56M$80.41M$82.59M$47.90M$45.23M$39.52M$36.89M$37.66M
Long-Term Debt$18.83M$20.08M$37.69Mn/an/an/an/a$0$97.0K$1.26M$2.43M
Shareholders' Equity$75.00M$74.72M$64.46M$54.76M$37.41M$35.69M$41.24M$38.41M$47.10M$47.73M$42.88M
Cash & Equivalents$8.25M$9.95M$14.94M$23.27M$8.08M$4.43M$5.21M$4.37M$10.65M$9.72M$12.51M
Operating Cash Flow$14.82M$18.63M$14.78M$19.56M-$3.79M-$7.88M$912.0K$4.16M$2.49M$3.18M$11.66M
Capital Expenditures$3.94M$3.94M$2.17M$4.37M$4.15M$1.91M$2.40M$2.46M$4.21M$3.40M$2.61M
Free Cash Flow$10.88M$14.70M$12.62M$15.19M-$7.94M-$9.79M-$1.49M$1.70M-$1.72M-$212.0K$9.05M
Share Repurchases$529.0K$0$1.60M$2.00M$0n/an/an/an/an/an/a
Dividends Paidn/an/an/an/an/an/a$0$1.04M$2.03M$1.79M$1.57M
Shares Outstanding2.90M2.87M2.84M2.84M2.83M2.79M2.76M2.75M2.75M2.73M2.71M
Dividends Per Sharen/an/an/an/an/an/an/a$0.38$0.74$0.66$0.58
Weighted Average Diluted Sharesn/a2.98M2.98M2.94M2.90M2.79M2.76M2.75M2.79M2.78M2.73M
EPS (Basic)n/a$3.36$3.98$6.51$0.26-$2.20-$1.33-$1.70$0.56$1.94$1.67

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView